galantamine and Atherosclerotic Parkinsonism

galantamine has been researched along with Atherosclerotic Parkinsonism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baqi, Y; Collins-Praino, LE; Kovner, R; Ledgard, F; Müller, CE; Paul, NE; Podurgiel, SJ; Salamone, JD; Senatus, PB1
Baqi, Y; Correa, M; Kovner, R; Müller, CE; Podurgiel, SJ; Salamone, JD; Spencer, T1
Shimohama, S1

Reviews

1 review(s) available for galantamine and Atherosclerotic Parkinsonism

ArticleYear
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:3

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord

2009

Other Studies

2 other study(ies) available for galantamine and Atherosclerotic Parkinsonism

ArticleYear
Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
    The European journal of neuroscience, 2013, Volume: 38, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Animals; Deep Brain Stimulation; Disease Models, Animal; Dopamine Antagonists; Galantamine; Jaw; Male; Movement; Parkinson Disease, Secondary; Pilocarpine; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus; Tremor; Xanthines

2013
Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
    Pharmacology, biochemistry, and behavior, 2016, Volume: 140

    Topics: Adenosine A2 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Jaw; Male; Mice; Mice, Inbred C57BL; Movement; Parkinson Disease, Secondary; Receptor, Adenosine A2A; Tremor; Xanthines

2016